Innate Pharma SA (IPH) A EUR0.05

Sell:€1.36Buy:€1.40Price increased€0.03 (1.93%)

Prices delayed by at least 15 minutes
Sell:€1.36
Buy:€1.40
Change:Price increased€0.03 (1.93%)
Prices delayed by at least 15 minutes
Sell:€1.36
Buy:€1.40
Change:Price increased€0.03 (1.93%)
Prices delayed by at least 15 minutes

Key metrics

Open€1.36
Previous close€1.35
Market cap€126.66m
P/E ratio-99999.99
Volume523,506
Dividend yield0.00%
EMS-

Innate Pharma SA is a France-based biopharmaceutical company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications, and ...

  • LocationFrance
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyEUR
  • Shares in issue93.72m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.